> 課題検索詳細
前に戻る
検索画面に戻る
研究課題情報
（単位：千円）
研究成果情報
1.Ishizuka K, Yoshida T, Kawabata T, Imai A, Mori H, Kimura H, Inada T, Okahisa Y, Egawa J, Usami M, Kushima I, Morikawa M, Okada T, Ikeda M, Branko A, Mori D, Someya T, Iwata N, Ozaki N. Functional characterization of rare NRXN1 variants identified in autism spectrum disorders and schizophrenia. J Neurodev Disord. 2020, 12, 25, doi:10.1186/s11689-020-09325-2.
2.Kato H, Kushima I, Mori D, Yoshimi A, Aleksic B, Nawa Y, Toyama M, Furuta S, Yu Y, Ishizuka K, Kimura H, Arioka Y, Tsujimura K, Morikawa M, Okada T, Inada T, Nakatochi M, Shinjo K, Kondo Y, Kaibuchi K, Funabiki Y, Kimura R, Suzuki T, Yamakawa K, Ikeda M, Iwata N, Takahashi T, Suzuki M, Okahisa Y, Takaki M, Egawa J, Someya T, Ozaki N. Rare genetic variants in the gene encoding histone lysine demethylase 4C (KDM4C) and their contributions to susceptibility to schizophrenia and autism spectrum disorder. Transl Psychiatry. 2020, 10, 421, doi:10.1038/s41398-020-01107-7.
3.Nawa Y, Kimura H, Mori D, Kato H, Toyama M, Furuta S, Yu Y, Ishizuka K, Kushima I, Aleksic B, Arioka Y, Morikawa M, Okada T, Inada T, Kaibuchi K, Ikeda M, Iwata N, Suzuki M, Okahisa Y, Egawa J, Someya T, Nishimura F, Sasaki T, Ozaki N. Rare single-nucleotide DAB1 variants and their contribution to Schizophrenia and autism spectrum disorder susceptibility. Hum Genome Var. 2020, 7, 37, doi:10.1038/s41439-020-00125-7.
4.Noda Y, Uchida M, Mouri A, Yamada S, Goto S, Kitagaki S, Mamiya T, Kushima I, Arioka Y, Ozaki N, Yoshimi A. Involvement of nicotinic acetylcholine receptors in behavioral abnormalities and psychological dependence in schizophrenia-like model mice. Eur Neuropsychopharmacol. 2020, 41, 92-105, doi:10.1016/j.euroneuro.2020.10.001.
5.Sawahata M, Mori D, Arioka Y, Kubo H, Kushima I, Kitagawa K, Sobue A, Shishido E, Sekiguchi M, Kodama A, Ikeda R, Aleksic B, Kimura H, Ishizuka K, Nagai T, Kaibuchi K, Nabeshima T, Yamada K, Ozaki N. Generation and analysis of novel Reln-deleted mouse model corresponding to exonic Reln deletion in schizophrenia. Psychiatry Clin Neurosci. 2020, 74, 318-327, doi:10.1111/pcn.12993.
6.Sekiguchi M, Sobue A, Kushima I, Wang C, Arioka Y, Kato H, Kodama A, Kubo H, Ito N, Sawahata M, Hada K, Ikeda R, Shinno M, Mizukoshi C, Tsujimura K, Yoshimi A, Ishizuka K, Takasaki Y, Kimura H, Xing J, Yu Y, Yamamoto M, Okada T, Shishido E, Inada T, Nakatochi M, Takano T, Kuroda K, Amano M, Aleksic B, Yamomoto T, Sakuma T, Aida T, Tanaka K, Hashimoto R, Arai M, Ikeda M, Iwata N, Shimamura T, Nagai T, Nabeshima T, Kaibuchi K, Yamada K, Mori D, Ozaki N. ARHGAP10, which encodes Rho GTPase-activating protein 10, is a novel gene for schizophrenia risk. Transl Psychiatry. 2020, 10, 247, doi:10.1038/s41398-020-00917-z.
7.Taniguchi S, Ninomiya K, Kushima I, Saito T, Shimasaki A, Sakusabe T, Momozawa Y, Kubo M, Kamatani Y, Ozaki N, Ikeda M, Iwata N. Polygenic risk scores in schizophrenia with clinically significant copy number variants. Psychiatry Clin Neurosci. 2020, 74, 35-39, doi:10.1111/pcn.12926.
8.Torii Y, Iritani S, Sekiguchi H, Habuchi C, Fujishiro H, Kushima I, Kawakami I, Itokawa M, Arai M, Hayashida S, Masaki K, Kira JI, Kawashima K, Ozaki N. The accumulation of advanced glycation end-products in a schizophrenic patient with a glyoxalase 1 frameshift mutation: An autopsy study. Schizophr Res. 2020, 223, 356-358, doi:10.1016/j.schres.2020.09.012.
9.Arioka Y, Shishido E, Kushima I, Suzuki T, Saito R, Aiba A, Mori D, Ozaki N. Chromosome 22q11.2 deletion causes PERK-dependent vulnerability in dopaminergic neurons. EBioMedicine. 2021, 63, 103138, doi:10.1016/j.ebiom.2020.103138.
10.Hada K, Wulaer B, Nagai T, Itoh N, Sawahata M, Sobue A, Mizoguchi H, Mori D, Kushima I, Nabeshima T, Ozaki N, Yamada K. Mice carrying a schizophrenia-associated mutation of the Arhgap10 gene are vulnerable to the effects of methamphetamine treatment on cognitive function: association with morphological abnormalities in striatal neurons. Mol Brain. 2021, 14, 21, doi:10.1186/s13041-021-00735-4.
11.Mizutani R, Saiga R, Yamamoto Y, Uesugi M, Takeuchi A, Uesugi K, Terada Y, Suzuki Y, De Andrade V, De Carlo F, Takekoshi S, Inomoto C, Nakamura N, Torii Y, Kushima I, Iritani S, Ozaki N, Oshima K, Itokawa M, Arai M. Structural diverseness of neurons between brain areas and between cases. Transl Psychiatry. 2021, 11, 49, doi:10.1038/s41398-020-01173-x.
12.Nakatochi M, Kushima I, Ozaki N. Implications of germline copy-number variations in psychiatric disorders: review of large-scale genetic studies. J Hum Genet. 2021, 66, 25-37, doi:10.1038/s10038-020-00838-1.
13.Sumiyoshi C, Narita Z, Inagawa T, Yamada Y, Sueyoshi K, Hasegawa Y, Shirama A, Hashimoto R, Sumiyoshi T. Facilitative effects of transcranial direct current stimulation on semantic memory examined by text-mining analysis in patients with schizophrenia. Frontiers in Neurology, 2021 Feb 11;12:583027.doi: 10.3389/fneur.2021.583027
14.Yamada Y., Sumiyoshi T.: Neurobiological mechanisms of transcranial direct current stimulation for psychiatric disorders; neurophysiological, chemical, and anatomical considerations. Front Hum Neurosci. 2021 Feb 4;15:631838. doi:10.3389/fnhum.2021.631838. eCollection 2021.
15.Sonderby IE, (55名中略), Hashimoto R (145 名中56番目), (88名中略), Andreassen OA; ENIGMA-CNV working group. 1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans. Transl. Psychiatry, 2021, 11(1):182, doi:10.1038/s41398-021-01213-0
16.Matsumoto J, Fukunaga M, Miura K, Nemoto K, Koshiyama D, Okada N, Morita K, Yamamori H, Yasuda Y, Fujimoto M, Hasegawa N, Watanabe Y, Kasai K, *Hashimoto R. Relationship between white matter microstructure and work hours. Neurosci Lett, 2021, 740:135428, doi:10.1016/j.neulet.2020.135428
17.Ichihashi K, Hori H, Hasegawa N, Yasuda Y, Yamamoto T, Tsuboi T, Iwamoto K, Kishimoto T, Horai T, Yamada H, Sugiyama N, Nakamura T, Tsujino N, Nemoto K, Oishi S, Usami M, Katsumoto E, Yamamori H, Tomita H, Suwa T, Furihata R, Inagaki T, Fujita J, Onitsuka T, Miura K, Matsumoto J, Ohi K, Matsui Y, Takaesu Y, Hashimoto N, Iga J, Ogasawara K, Yamada H, Watanabe K, Inada K, *Hashimoto R. Prescription patterns in patients with schizophrenia in Japan: First-quality indicator data from the survey of Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)" project. Neuropsychopharmacol Rep, 2020, 40(3):281-286, doi:10.1002/npr2.12122."
1.本邦のオンライン診療エビデンスと大学病院外来精神科遠隔医療の実践からの考察, 岸本 泰士郎, 第33回日本総合病院精神医学会総会, 2020/12/7-13, 国内, 口頭
国内 / 口頭
2.COVID-19パンデミック下での、諸外国の遠隔精神科医療の規制緩和について, 木下 翔太郎, Kelley Cortright, 岸本 泰士郎, 第33回日本総合病院精神医学会総会, 2020/12/7-13, 国内, 口頭
3.オンライン診療やAIを活用した今後のうつ病治療の展望, 岸本 泰士郎, Meet The Expert in 三重 ～精神科の未来を考える～, 2020/12/11, 国内, 口頭
4.ICTやAIを活用した精神科医療の展望, 岸本 泰士郎, 第15回全国てんかんリハビリテーション研究会, 2020/12/12, 国内, 口頭
5.遠隔医療やAIを活用した近未来の精神科医療の展望, 岸本 泰士郎, 第157回日本医学会, 2020/12/19, 国内, 口頭
6.情報通信機器や人工知能の活用で今後の精神科医療は変わるか, 岸本 泰士郎, 第45回不安抑うつ臨床研究会のご案内, 2021/1/9, 国内, 口頭
7.COVID-19 response: An overview of a survey of 17 countries and how the introduction of telemedicine in Japan is progressing, Kishimoto T, The 25th ISfTeH International Conference in JAPAN, Virtual Conference, 2021/2/11-25, 国外, 口頭
国外 / 口頭
8.Prospects for psychiatry practice in the era of digital transformation: Focusing on early intervention and prevention, Kishimoto T, The 25th ISfTeH International Conference in JAPAN, 2021/2/11-25, 国外, 口頭
9.What evidence will be needed for telepsychiatry considering its use during and following the COVID-19 pandemic? , Kishimoto T, The 25th ISfTeH International Conference in JAPAN, 2021/2/11-25, 国外, 口頭
10.精神科領域のオンライン診療エビデンス, 岸本 泰士郎, 第24回日本遠隔医療学会学術大会, 2021/2/11-25, 国内, 口頭
11.オンライン診療やAIを活用した今後のうつ病治療の展望, 岸本 泰士郎, MDDシンポジウム～精神科医療の進歩～, 2021/2/18, 国内, 口頭
12.ICTやAIを用いた近未来の精神科医療の展望, 岸本 泰士郎, Psychiatric Web Conference, 2021/3/17, 国内, 口頭
13.ICTやAIの活用で精神科医療はどう変わるか？, 岸本 泰士郎, 第2回これからの精神科医療を考える会 2021/3/19, 国内, 口頭
14.ゲノム医療の現状と今後の方向性、尾崎紀夫、日本医療薬学会年会、2020/9/20、国内、口頭
15.多施設共同研究とゲノム情報の集約により精神疾患の病態解明から根本的治療薬開発へ、尾崎紀夫、NPBPPPP2020 シンポジウム本邦における精神科領域の個別化医療技術開発とバイオバンキングの展望、2020、国内、口頭
16.自閉スペクトラム症ゲノム解析の現状、尾崎紀夫、児童青年精神医学会:シンポジウム１「最新の自閉症学」、2020/10/24、国内、口頭
17.精神疾患のゲノム解析を起点とした病態解明から創薬へ、尾崎紀夫、日本人類遺伝学会・教育セッション、2020/11/20、国内、口頭
18.Yokoi Y., Inagawa T., Yamada, Y., Sumiyoshi T.: Transcranial direct current stimulation in patients with dementia or mild cognitive impairment. In Symposium "Electrophysiological Evaluation and Modulation of Symptoms and Functional Outcomes in Psychosis", 20th WPA World Congress of Psychiatry, 2021, 3, 10 Virtual Congress (2021, 3, 10 - 13) (Invited lecture) (国外、口演)
国外 / 講演
19.Yamada, Y., Inagawa T., Sueyoshi K., Wada A., Shirama A., Sumiyoshi T.: Transcranial direct current stimulation to enhance specific domains of cognitive function in schizophrenia. In Symposium "Electrophysiological Evaluation and Modulation of Symptoms and Functional Outcomes in Psychosis", 20th WPA World Congress of Psychiatry, 2021, 3, 10 Virtual Congress (2021, 3, 10 - 13) (Invited lecture) (国外、口演)
20.Sumiyoshi T., Yamada Y., Inagawa T., Shirama A., Sueyoshi K., Hasegawa Y., Wada A., Narita Z., Yokoi Y: Transcranial direct current stimulation to improve functional outcomes in schizophrenia. In Symposium "Neuromodulation Psychiatric Electrophysiology - Current and Future Perspectives for Diagnosis and Treatment ", 20th WPA World Congress of Psychiatry, 2021, 3, 10 Virtual Congress (2021, 3, 10 - 13) (Invited lecture) (国外、口演)
1.こころの病気と遺伝inこころの病気について、石塚佳奈子・夏苅郁子・尾崎紀夫、日本精神神経学会、2021、https://www.jspn.or.jp/modules/forpublic/index.php?content_id=56、WEB掲載
不明
2.妊産婦の方に生じるこころの変化：理解と支えのために、尾崎紀夫、2020年度 公益財団法人JKA公益事業振興補助事業「女性のライフステージと女性特有のうつとの関係」、2021/2/21、WEBオンラインセミナー
3.働く女性のメンタルヘルス：妊娠から出産・育児を通したメンタルヘルス、尾崎紀夫、2019年度 公益財団法人JKA公益事業振興補助事業「産後うつ病と妊産婦自殺防止に関する啓発事業」、2020/9/6、WEBオンラインシンポジウム
4.コロナ禍の社会で暮らす当事者のために精神医学は何かできるのか：妊娠・出産から自動車運転まで、尾崎紀夫、NPBPPPP2020市民公開講座、2020、オンラインセミナー
更新日：2022-05-12
